A biomedical engineering team from a health sciences university in Istanbul is seeking to join consortia under Horizon Europe calls related to bioprinting and NAMs. Their expertise includes bio-ink development, 3D bioprinting, organoid models, and in vitro drug testing. They offer advanced hydrogel-based constructs and disease modeling platforms for regenerative medicine and precision research.
Ref.RDRMD20260622006.Un hospital terciario de Moldavia con cepas resistentes a los antimicrobianos busca socios de I+D para el programa Horizonte Europa(HORIZON-HLTH-2027-01-DISEASE-08).
A tertiary hospital in the Republic of Moldova, with about 30 clinical departments, 772 beds and an active clinical microbiology laboratory, seeks R&D partners for Horizon Europe call HORIZON-HLTH-2027-01-DISEASE-08 on innovative antimicrobials. The hospital...
Jun 25, 2026















